The IgA isotype of anti-β2 glycoprotein I antibodies recognizes epitopes in domains 3, 4, and 5 that are located in a lateral zone of the molecule (L-Shaped)

M Serrano, JA Martinez-Flores, GL Norman… - Frontiers in …, 2019 - frontiersin.org
Background: Antiphospholipid syndrome (APS) is characterized by thrombosis and/or
pregnancy morbidity with presence of anti-phospholipid antibodies (aPL). The APS …

The weight of IgA anti-β2glycoprotein I in the antiphospholipid syndrome pathogenesis: closing the gap of seronegative antiphospholipid syndrome

O Cabrera-Marante, E Rodríguez de Frías… - International Journal of …, 2020 - mdpi.com
The specific value of IgA Anti-β2glycoprotein I antibodies (aB2GP1) in the diagnosis and
management of antiphospholipid syndrome (APS) is still controversial and a matter of active …

Antiphospholipid antibodies to domain I of beta-2-glycoprotein I show different subclass predominance in comparison to antibodies to whole beta-2-glycoprotein I

T McDonnell, B Artim-Esen, C Wincup… - Frontiers in …, 2018 - frontiersin.org
Antiphospholipid antibodies (aPL), the serological hallmark of antiphospholipid syndrome
(APS), are a heterogeneous group of autoantibodies raised against circulating blood …

Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess

D Perez, A Tincani, M Serrano, Y Shoenfeld… - Lupus, 2018 - journals.sagepub.com
IgA anti-beta2-glycoprotein I (IgA-aB2GPI) antibodies are currently not included as a
laboratory criterion of antiphospholipid syndrome (APS). In the 13th International Congress …

New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies

CB Chighizola, M Gerosa, PL Meroni - Current rheumatology reports, 2014 - Springer
Abstract Beta-2 glycoprotein I (β 2 GPI) is the main antigenic target for antiphospholipid
antibodies (aPL), the serological markers of antiphospholipid syndrome (APS). Domain I (DI) …

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome

CB Chighizola, F Pregnolato, L Andreoli, C Bodio… - Journal of …, 2018 - Elsevier
Antibodies against β2 glycoprotein I (anti-β2GPI) have been identified as the main
pathogenic autoantibody subset in anti-phospholipid syndrome (APS); the most relevant …

Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAs

L Pelkmans, H Kelchtermans, PG de Groot, S Zuily… - PloS one, 2013 - journals.plos.org
Background A major problem for diagnosing the antiphospholipid syndrome (APS) is the
high variability between commercial anti-β2glycoprotein I (β2GPI) assays. Predominantly …

Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies

C Tortosa, O Cabrera-Marante, M Serrano… - PLoS …, 2017 - journals.plos.org
Background The antiphospholipid syndrome (APS) is defined by simultaneous presence of
vascular clinical events and antiphospholipid antibodies (aPL). The aPL considered as …

Circulating immune complexes of IgA bound to beta 2 glycoprotein are strongly associated with the occurrence of acute thrombotic events

JA Martínez-Flores, M Serrano, D Pérez… - … of Atherosclerosis and …, 2016 - jstage.jst.go.jp
Aim: Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis and/or
gestational morbidity in patients with antiphospholipid autoantibodies (aPL). Over recent …

Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients

J Guerin, E Casey, C Feighery, J Jackson - Autoimmunity, 1999 - Taylor & Francis
Beta 2-glycoprotein I (β2-GPI) is an antigenic target recognised by antiphospholipid
antibodies found in association with the antiphospholipid syndrome (APS). In this study, the …